Haleon (HLN) Other Non-Current Assets (2021 - 2026)
Haleon's (HLN) quarterly Other Non-Current Assets came in at $56.4 million in Q2 2026, up 13.67% on a QoQ basis from $49.6 million in Q4 2025.
Haleon (HLN) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Haleon (HLN) has 6 years of Other Non-Current Assets data on file, last reported at $56.4 million in Q2 2026.
- Quarterly Other Non-Current Assets changed N/A year-over-year to $56.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $56.4 million (changed N/A YoY) and the FY2025 annual result came in at $49.2 million, down 53.05% from the prior year.
- Other Non-Current Assets climbed to $56.4 million in Q2 2026, from $49.6 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $154.8 million in Q4 2022 to a low of $49.6 million in Q4 2025.
- A 5-year average of $100.5 million and a median of $101.9 million in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 1335.69% — and 2025, when it slumped 52.9%.
- Tracing HLN's Other Non-Current Assets over 5 years: stood at $154.8 million in 2022, then dropped by 8.61% to $141.5 million in 2023, then dropped by 25.62% to $105.2 million in 2024, then tumbled by 52.9% to $49.6 million in 2025, then gained by 13.67% to $56.4 million in 2026.
- The last three Other Non-Current Assets figures came in at $56.4 million (Q2 2026), $49.6 million (Q4 2025), and $105.2 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 13.00 Mn |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | 62.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.35 Mn |
| Dec 31, 2025 | 49.57 Mn |
| Dec 31, 2024 | 105.25 Mn |
| Jun 30, 2024 | 98.45 Mn |
| Dec 31, 2023 | 141.49 Mn |
| Jun 30, 2023 | 141.40 Mn |
| Dec 31, 2022 | 154.83 Mn |
| Jun 30, 2022 | 56.67 Mn |
| Dec 31, 2021 | 10.78 Mn |